Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy

K Ajiki1, Y Murakawa, A Yanagisawa-Miwa

  • 12nd Department of Internal Medicine, Tokyo University Hospital, Japan.

Insights

Autonomic nervous system imbalance, marked by reduced parasympathetic and increased sympathetic activity, is evident in patients with cardiomyopathies. Heart rate variability analysis reveals these changes, aiding in understanding disease pathophysiology.

Area of Science:

  • Cardiology
  • Autonomic Neuroscience

Background:

  • Cardiomyopathies are characterized by structural and functional abnormalities of the heart muscle.
  • Autonomic nervous system dysfunction is increasingly recognized as a contributing factor in cardiovascular diseases.

Purpose of the Study:

  • To evaluate autonomic nervous system activity in patients with idiopathic dilated cardiomyopathy (IDC) and hypertrophic cardiomyopathy (HC).
  • To correlate heart rate variability (HRV) findings with disease characteristics.

Main Methods:

  • 24-hour ambulatory electrocardiograms were used to analyze heart rate variability.
  • Fast-Fourier transform was applied to quantify power spectra in low-frequency (LF) and high-frequency (HF) bands.
  • Log(HF) and Log(LF/HF) were used as indices for parasympathetic and sympathetic activity, respectively.

Main Results:

  • Patients with IDC showed significantly lower parasympathetic activity (Log(HF)) and higher sympathetic activity (Log(LF/HF)), related to ejection fraction.
  • Patients with HC exhibited reduced parasympathetic and enhanced sympathetic activity primarily during nighttime, independent of hypertrophy severity.

Conclusions:

  • Cardiomyopathies are associated with significant autonomic nervous system imbalance.
  • HRV analysis is a valuable tool for assessing autonomic dysfunction in cardiomyopathies and understanding their pathophysiology.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...